Puma Biotechnology Inc (NYSE:PBYI)

During the Trading Day
222.00 +23.99 / +12.12%
Data as of 4:02pm ET
Day’s Change
During After-Hours   Switch to standard view »
221.20 -0.80 / -0.36%
 
Volume: 1.8K
Why Puma Biotechnology, Inc. Stock Receded Today
Jul 24 / MotleyFool.com
Unusual 11 Mid-Day Movers 07/23: (PBYI) (DRL) (NQ) Higher; (UIS) (XLNX) (NETE) Lower
Jul 23 / Investing Channel
Earnings Beats Drive ETFs; LinkedIn Boosts Social Media ETF
Jul 24 / Benzinga
Puma Shares Soar When Wall Street Misplays Expectation Game
Jul 23 / TheStreet.com
Puma Biotechnology (PBYI) is in Overbought Territory: What's Next? - Tale of the Tape
Jul 24 / Zacks.com
Benzinga's Volume Movers
Jul 23 / Benzinga
Every Which Way But Short
Jul 24 / TheStreet.com
Stocks Hitting 52-Week Highs
Jul 23 / Benzinga
What Will Puma Biotechnology Inc's $700 Million Man Do Next?
Jul 23 / MotleyFool.com
Morning Market Movers
Jul 23 / Benzinga
Jim Cramer's 'Mad Money' Recap: Unconventional Wisdom
Jul 23 / TheStreet.com
Jim Cramer's Mad Dash: Puma Biotechnology Proves Valuing Biotech Is Hard
Jul 23 / TheStreet.com
295% Pop: Too Late to Buy Puma Biotechnology Stock?
Jul 23 / MotleyFool.com
Pre-Open Stock Movers 7/23 (PBYI) (ISRG) (BIIB) Higher; (XNLX) (MEET) (XOOM) Lower (m...
Jul 23 / Investing Channel
Puma Biotechnology Stock Shoves It in Short Sellers' Faces
Jul 23 / MotleyFool.com
Wednesdaybs Top Health Care Stories: Puma, Biogen, and Intuitive Surgical
Jul 23 / MotleyFool.com
Notable 52-Week Highs and Lows of the Day 07/23: (PBYI) (AAPL) (DOW) High; (XLNX) (UI...
Jul 23 / Investing Channel
Puma Biotechnology Inc's Overnight Triple is Just the Beginning
Jul 22 / MotleyFool.com
Puma Biotechnology Stock Is Flying; Time to Buy?
Jul 23 / MotleyFool.com
After-Hours Stock Movers 7/22: (PBYI) (TLM) (ISRG) Higher; (XOOM) (XLNX) (AAPL) Lower...
Jul 22 / Investing Channel
Why Puma Biotechnology (PBYI) Stock Is SpikingToday?
Jul 23 / TheStreet.com
Puma Bio Rips More Than $100 After-Hours On Trial Results For Breast Cancer
Jul 22 / Benzinga
Puma Biotech Surges on Positive Results on Neratinib - Analyst Blog
Jul 23 / Zacks.com
Puma Biotechnology Announces Positive Top Line Results From Phase III PB272 Trial In ...
Jul 22 / Benzinga
Why Puma Biotechnology Inc Stock More Than Tripled Today
Jul 23 / MotleyFool.com
Puma Biotechnology Announces Amendment To Neratinib Licensing Agreement With Pfizer
Jul 22 / Benzinga

To view my watchlist

Not a member yet?

Sign up now for a free account
Market indexes are shown in real time, except for the DJIA, which is delayed by two minutes. All times are ET. Disclaimer Morningstar: © 2014 Morningstar, Inc. All Rights Reserved. Disclaimer The Dow Jones IndexesSM are proprietary to and distributed by Dow Jones & Company, Inc. and have been licensed for use. All content of the Dow Jones IndexesSM © 2014 is proprietary to Dow Jones & Company, Inc. Chicago Mercantile Association. The market data is the property of Chicago Mercantile Exchange Inc. and its licensors. All rights reserved. FactSet Research Systems Inc. 2014. All rights reserved. Most stock quote data provided by BATS.